speb/financial-data huggingface dataset:
XYL cash_flow (annual, 2024-12-31) — Change In Receivables: -144000000.00
XYL cash_flow (annual, 2024-12-31) — Change In Working Capital: -112000000.00
XYL cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -107000000.00
XYL cash_flow (annual, 2024-12-31) — Changes In Cash: 166000000.00
XYL balance_sheet (annual, 2024-12-31) — Common Stock: 3000000.00
XYL cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -350000000.00
XYL balance_sheet (annual, 2024-12-31) — Common Stock Equity: 10642000000.00
XYL cash_flow (annual, 2024-12-31) — Common Stock Payments: -20000000.00
XYL balance_sheet (annual, 2024-12-31) — Construction In Progress: 228000000.00
XYL balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 228000000.00
XYL income_statement (annual, 2024-12-31) — Cost Of Revenue: 5350000000.00
XYL balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 552000000.00
XYL balance_sheet (annual, 2024-12-31) — Current Assets: 4098000000.00
XYL balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 109000000.00
XYL balance_sheet (annual, 2024-12-31) — Current Debt: 38000000.00
XYL balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 147000000.00
XYL balance_sheet (annual, 2024-12-31) — Current Liabilities: 2336000000.00
XYL cash_flow (annual, 2024-12-31) — Deferred Income Tax: -36000000.00
XYL cash_flow (annual, 2024-12-31) — Deferred Tax: -36000000.00
XYL cash_flow (annual, 2024-12-31) — Depreciation: 258000000.00
XYL cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 562000000.00
XYL cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 562000000.00
XYL income_statement (annual, 2024-12-31) — Diluted Average Shares: 243500000.00
XYL income_statement (annual, 2024-12-31) — Diluted EPS: 3.65
XYL income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 890000000.00
XYL income_statement (annual, 2024-12-31) — EBIT: 1131000000.00
XYL income_statement (annual, 2024-12-31) — EBITDA: 1693000000.00
XYL income_statement (annual, 2024-12-31) — Earnings From Equity Interest: 148000000.00
XYL cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -53000000.00
XYL balance_sheet (annual, 2024-12-31) — Employee Benefits: 304000000.00
XYL cash_flow (annual, 2024-12-31) — End Cash Position: 1121000000.00
XYL cash_flow (annual, 2024-12-31) — Financing Cash Flow: -615000000.00
XYL balance_sheet (annual, 2024-12-31) — Finished Goods: 341000000.00
XYL cash_flow (annual, 2024-12-31) — Free Cash Flow: 942000000.00
XYL cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 46000000.00
XYL income_statement (annual, 2024-12-31) — Gain On Sale Of Business: -46000000.00
XYL balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -435000000.00
XYL income_statement (annual, 2024-12-31) — General And Administrative Expense: 1911000000.00
XYL balance_sheet (annual, 2024-12-31) — Goodwill: 7980000000.00
XYL balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 10359000000.00
XYL balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 1727000000.00
XYL balance_sheet (annual, 2024-12-31) — Gross PPE: 2586000000.00
XYL balance_sheet (quarterly, 2024-12-31) — Gross PPE: 2586000000.00
XYL income_statement (annual, 2024-12-31) — Gross Profit: 3212000000.00
XYL cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 219000000.00
XYL income_statement (annual, 2024-12-31) — Interest Expense: 44000000.00
XYL income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 44000000.00
XYL income_statement (annual, 2024-12-31) — Interest Income: 28000000.00
XYL income_statement (annual, 2024-12-31) — Interest Income Non Operating: 28000000.00
XYL cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 67000000.00
XYL balance_sheet (annual, 2024-12-31) — Inventory: 996000000.00
XYL balance_sheet (annual, 2024-12-31) — Invested Capital: 12658000000.00
XYL cash_flow (annual, 2024-12-31) — Investing Cash Flow: -482000000.00
XYL cash_flow (annual, 2024-12-31) — Issuance Of Debt: 1000000.00
XYL balance_sheet (annual, 2024-12-31) — Long Term Debt: 1978000000.00
XYL balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1978000000.00
XYL cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 1000000.00
XYL cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 1000000.00
XYL cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -17000000.00
XYL balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 1492000000.00
XYL balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 1492000000.00
XYL balance_sheet (annual, 2024-12-31) — Minority Interest: 240000000.00
XYL income_statement (annual, 2024-12-31) — Minority Interests: 0.00
XYL cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -182000000.00
XYL cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -20000000.00
XYL balance_sheet (annual, 2024-12-31) — Net Debt: 895000000.00
XYL income_statement (annual, 2024-12-31) — Net Income: 890000000.00
XYL income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 890000000.00
XYL income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 890000000.00
XYL income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 890000000.00
XYL income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 890000000.00
XYL cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 890000000.00
XYL income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 890000000.00
XYL income_statement (annual, 2024-12-31) — Net Interest Income: -16000000.00
XYL cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 18000000.00
XYL cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -284000000.00
XYL cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -16000000.00
XYL income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -16000000.00
XYL cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -28000000.00
XYL cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -1000000.00
XYL balance_sheet (annual, 2024-12-31) — Net PPE: 1152000000.00
XYL cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 4000000.00
XYL cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: -268000000.00
XYL balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 283000000.00
XYL balance_sheet (annual, 2024-12-31) — Non Current Accrued Expenses: 496000000.00
XYL balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 497000000.00
XYL balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 497000000.00
XYL balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 304000000.00
XYL income_statement (annual, 2024-12-31) — Normalized EBITDA: 1801000000.00
XYL income_statement (annual, 2024-12-31) — Normalized Income: 978452000.00
XYL cash_flow (annual, 2024-12-31) — Operating Cash Flow: 1263000000.00
XYL cash_flow (annual, 2024-12-31) — Operating Gains Losses: 46000000.00
XYL income_statement (annual, 2024-12-31) — Operating Income: 1071000000.00
XYL income_statement (annual, 2024-12-31) — Operating Revenue: 8562000000.00
XYL balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 243000000.00
XYL cash_flow (annual, 2024-12-31) — Other Cash Adjustment Outside Changein Cash: -11000000.00
XYL balance_sheet (annual, 2024-12-31) — Other Current Assets: 236000000.00
XYL balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 38000000.00
XYL balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 21000000.00
XYL balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 21000000.00
XYL balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -435000000.00
XYL income_statement (annual, 2024-12-31) — Other Gand A: 1911000000.00
XYL income_statement (annual, 2024-12-31) — Other Income Expense: 32000000.00
XYL balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 2379000000.00
XYL cash_flow (annual, 2024-12-31) — Other Non Cash Items: 9000000.00
XYL cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 0.00
XYL balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 884000000.00
XYL income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -8000000.00
XYL income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: -19000000.00
XYL balance_sheet (annual, 2024-12-31) — Other Properties: 389000000.00
XYL balance_sheet (quarterly, 2024-12-31) — Other Properties: 389000000.00
XYL balance_sheet (annual, 2024-12-31) — Payables: 1207000000.00
XYL balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 1759000000.00
XYL cash_flow (annual, 2024-12-31) — Pension And Employee Benefit Expense: 0.00
XYL balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 409000000.00
XYL income_statement (annual, 2024-12-31) — Pretax Income: 1087000000.00
XYL cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 67000000.00
XYL balance_sheet (annual, 2024-12-31) — Properties: 477000000.00
XYL balance_sheet (quarterly, 2024-12-31) — Properties: 477000000.00
XYL cash_flow (annual, 2024-12-31) — Purchase Of Business: -193000000.00
XYL cash_flow (annual, 2024-12-31) — Purchase Of Investment: -17000000.00
XYL balance_sheet (annual, 2024-12-31) — Raw Materials: 555000000.00
XYL balance_sheet (annual, 2024-12-31) — Receivables: 1668000000.00
XYL income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 5350000000.00
XYL income_statement (annual, 2024-12-31) — Reconciled Depreciation: 562000000.00
XYL cash_flow (annual, 2024-12-31) — Repayment Of Debt: -285000000.00
XYL cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -20000000.00
XYL income_statement (annual, 2024-12-31) — Research And Development: 230000000.00
XYL income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 55000000.00
XYL balance_sheet (annual, 2024-12-31) — Retained Earnings: 3140000000.00
XYL income_statement (annual, 2024-12-31) — Salaries And Wages: 0.00
XYL cash_flow (annual, 2024-12-31) — Sale Of Business: 11000000.00
XYL cash_flow (annual, 2024-12-31) — Sale Of Investment: 35000000.00
XYL cash_flow (annual, 2024-12-31) — Sale Of PPE: 4000000.00
XYL income_statement (annual, 2024-12-31) — Selling General And Administration: 1911000000.00
XYL balance_sheet (annual, 2024-12-31) — Share Issued: 259200000.00
XYL cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 0.00
XYL cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -268000000.00
XYL cash_flow (quarterly, 2024-12-31) — Short Term Debt Payments: 0.00
XYL income_statement (annual, 2024-12-31) — Special Income Charges: -108000000.00
XYL cash_flow (annual, 2024-12-31) — Stock Based Compensation: 56000000.00
XYL balance_sheet (annual, 2024-12-31) — Stockholders Equity: 10642000000.00
XYL balance_sheet (annual, 2024-12-31) — Tangible Book Value: 283000000.00
XYL income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -19548000.00
XYL income_statement (annual, 2024-12-31) — Tax Provision: 197000000.00
XYL income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.18
XYL balance_sheet (annual, 2024-12-31) — Total Assets: 16493000000.00
XYL balance_sheet (annual, 2024-12-31) — Total Capitalization: 12620000000.00
XYL balance_sheet (annual, 2024-12-31) — Total Debt: 2125000000.00
XYL balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 10882000000.00
XYL income_statement (annual, 2024-12-31) — Total Expenses: 7491000000.00
XYL balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 5611000000.00
XYL balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 12395000000.00
XYL balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 3275000000.00
XYL income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 1009000000.00
XYL balance_sheet (annual, 2024-12-31) — Total Tax Payable: 201000000.00
XYL income_statement (annual, 2024-12-31) — Total Unusual Items: -108000000.00
XYL income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -108000000.00
XYL balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 16200000.00
XYL balance_sheet (annual, 2024-12-31) — Treasury Stock: 753000000.00
XYL cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -152000000.00
XYL balance_sheet (annual, 2024-12-31) — Work In Process: 100000000.00
XYL balance_sheet (annual, 2024-12-31) — Working Capital: 1762000000.00
XYL income_statement (annual, 2024-12-31) — Write Off: 7000000.00
XYL income_statement (quarterly, 2025-03-31) — +Operating Expense: 516000000.00
XYL income_statement (quarterly, 2025-03-31) — +Total Revenue: 2069000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 958000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1743000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 8705000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -53000000.00
XYL cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 77000000.00
XYL cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 77000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 0.00
XYL income_statement (quarterly, 2025-03-31) — Basic Average Shares: 243100000.00
XYL income_statement (quarterly, 2025-03-31) — Basic EPS: 0.69
XYL cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 1121000000.00
XYL cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -71000000.00
XYL cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -71000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 121000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Capital Stock: 3000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1059000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1059000000.00
XYL cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -98000000.00
XYL cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -116000000.00
XYL cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -15000000.00
XYL cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 33000000.00
XYL cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -64000000.00
XYL cash_flow (quarterly, 2025-03-31) — Change In Inventory: -9000000.00
XYL cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -161000000.00
XYL cash_flow (quarterly, 2025-03-31) — Change In Payable: -64000000.00
XYL cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -64000000.00
XYL cash_flow (quarterly, 2025-03-31) — Change In Receivables: -80000000.00
XYL cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -314000000.00
XYL cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -48000000.00
XYL cash_flow (quarterly, 2025-03-31) — Changes In Cash: -98000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Common Stock: 3000000.00
XYL cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -98000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 10816000000.00
XYL cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -13000000.00
XYL income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1301000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 543000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Current Assets: 4084000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 121000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Current Debt: 41000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 162000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 2166000000.00
XYL cash_flow (quarterly, 2025-03-31) — Depreciation: 68000000.00
XYL cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 145000000.00
XYL cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 145000000.00
XYL income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 243800000.00
XYL income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.69
XYL income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 169000000.00
XYL income_statement (quarterly, 2025-03-31) — EBIT: 225000000.00
XYL income_statement (quarterly, 2025-03-31) — EBITDA: 370000000.00
XYL cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 25000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 317000000.00
XYL cash_flow (quarterly, 2025-03-31) — End Cash Position: 1059000000.00
XYL cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -116000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Finished Goods: 356000000.00
XYL cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -38000000.00
XYL cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of Business: 10000000.00
XYL income_statement (quarterly, 2025-03-31) — Gain On Sale Of Business: -10000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -337000000.00
XYL income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 460000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Goodwill: 8061000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 10393000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 1796000000.00
XYL income_statement (quarterly, 2025-03-31) — Gross Profit: 768000000.00
XYL cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 37000000.00
XYL income_statement (quarterly, 2025-03-31) — Interest Expense: 8000000.00
XYL income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 8000000.00
XYL cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 12000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Inventory: 1022000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Invested Capital: 12831000000.00
XYL cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -15000000.00
XYL cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 1000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1974000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1974000000.00
XYL cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -4000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Minority Interest: 238000000.00
XYL income_statement (quarterly, 2025-03-31) — Minority Interests: 2000000.00
XYL cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 41000000.00
XYL cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -13000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Net Debt: 956000000.00
XYL income_statement (quarterly, 2025-03-31) — Net Income: 169000000.00
XYL income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 169000000.00
XYL income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 167000000.00
XYL income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 169000000.00
XYL income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 169000000.00
XYL cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 169000000.00
XYL income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 167000000.00
XYL income_statement (quarterly, 2025-03-31) — Net Interest Income: -8000000.00
XYL cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 11000000.00
XYL cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -3000000.00
XYL cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -4000000.00
XYL income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -8000000.00
XYL cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -8000000.00
XYL cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -1000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Net PPE: 1157000000.00
XYL cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 5000000.00
XYL cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 1000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 423000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Non Current Accrued Expenses: 562000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 486000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 486000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 317000000.00
XYL income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 401000000.00
XYL income_statement (quarterly, 2025-03-31) — Normalized Income: 192839000.00
XYL cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 33000000.00
XYL cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 10000000.00
XYL income_statement (quarterly, 2025-03-31) — Operating Income: 252000000.00
XYL income_statement (quarterly, 2025-03-31) — Operating Revenue: 2069000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 243400000.00
XYL cash_flow (quarterly, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: 11000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 260000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 41000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -337000000.00
XYL income_statement (quarterly, 2025-03-31) — Other Gand A: 460000000.00
XYL income_statement (quarterly, 2025-03-31) — Other Income Expense: -27000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 2332000000.00
XYL cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 11000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 925000000.00
XYL income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 4000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Payables: 1177000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1720000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 284000000.00
XYL income_statement (quarterly, 2025-03-31) — Pretax Income: 217000000.00
XYL cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 6000000.00
XYL cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -7000000.00
XYL cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -1000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Raw Materials: 555000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Receivables: 1743000000.00
XYL income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1301000000.00
XYL income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 145000000.00
XYL cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -4000000.00
XYL cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -13000000.00
XYL income_statement (quarterly, 2025-03-31) — Research And Development: 56000000.00
XYL income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 17000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 3211000000.00
XYL cash_flow (quarterly, 2025-03-31) — Sale Of Business: 48000000.00
XYL cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 12000000.00
XYL cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 5000000.00
XYL income_statement (quarterly, 2025-03-31) — Selling General And Administration: 460000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Share Issued: 259700000.00
XYL cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 1000000.00
XYL income_statement (quarterly, 2025-03-31) — Special Income Charges: -31000000.00
XYL cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 12000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 10816000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 423000000.00
XYL income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -7161000.00
XYL income_statement (quarterly, 2025-03-31) — Tax Provision: 50000000.00
XYL income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.23
XYL balance_sheet (quarterly, 2025-03-31) — Total Assets: 16559000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 12790000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Total Debt: 2136000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 11054000000.00
XYL income_statement (quarterly, 2025-03-31) — Total Expenses: 1817000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 5505000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 12475000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 3339000000.00
XYL income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 231000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 219000000.00
XYL income_statement (quarterly, 2025-03-31) — Total Unusual Items: -31000000.00
XYL income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -31000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 16300000.00
XYL balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 766000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Work In Process: 111000000.00
XYL balance_sheet (quarterly, 2025-03-31) — Working Capital: 1918000000.00
XYL income_statement (quarterly, 2025-03-31) — Write Off: 4000000.00
XYL income_statement (quarterly, 2025-06-30) — +Operating Expense: 561000000.00
XYL income_statement (quarterly, 2025-06-30) — +Total Revenue: 2301000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1047000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 1837000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 8720000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -61000000.00
XYL cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 76000000.00
XYL cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 76000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 8000000.00
XYL cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1059000000.00
XYL cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -98000000.00
XYL cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -98000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 128000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Capital Stock: 3000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1170000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1170000000.00
XYL cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -98000000.00
XYL cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -128000000.00
XYL cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -125000000.00
XYL cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 305000000.00
XYL cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 70000000.00
XYL cash_flow (quarterly, 2025-06-30) — Change In Inventory: -18000000.00
XYL cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -64000000.00
XYL cash_flow (quarterly, 2025-06-30) — Change In Payable: 70000000.00
XYL cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 20000000.00
XYL cash_flow (quarterly, 2025-06-30) — Change In Receivables: -23000000.00
XYL cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -85000000.00
XYL cash_flow (quarterly, 2025-06-30) — Changes In Cash: 52000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Common Stock: 3000000.00
XYL cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -98000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 11074000000.00
XYL cash_flow (quarterly, 2025-06-30) — Common Stock Payments: 0.00
XYL income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1409000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 555000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Current Assets: 4369000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 128000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Current Debt: 68000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 196000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 2301000000.00
XYL cash_flow (quarterly, 2025-06-30) — Depreciation: 69000000.00
XYL cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 145000000.00
XYL cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 145000000.00
XYL income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 243900000.00
XYL income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 226000000.00
XYL income_statement (quarterly, 2025-06-30) — EBIT: 308000000.00
XYL income_statement (quarterly, 2025-06-30) — EBITDA: 453000000.00
XYL cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 59000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 340000000.00
XYL cash_flow (quarterly, 2025-06-30) — End Cash Position: 1170000000.00
XYL cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -128000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Finished Goods: 377000000.00
XYL cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 207000000.00
XYL cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of Business: 0.00
XYL income_statement (quarterly, 2025-06-30) — Gain On Sale Of Business: 0.00
XYL balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -222000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Goodwill: 8237000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 10591000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 1898000000.00
XYL income_statement (quarterly, 2025-06-30) — Gross Profit: 892000000.00
XYL cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 138000000.00
XYL income_statement (quarterly, 2025-06-30) — Interest Expense: 9000000.00
XYL income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 9000000.00
XYL cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 20000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Inventory: 1071000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Invested Capital: 13070000000.00
XYL cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -125000000.00
XYL cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 3000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 1928000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 1928000000.00
XYL cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -24000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Minority Interest: 235000000.00
XYL income_statement (quarterly, 2025-06-30) — Minority Interests: 2000000.00
XYL cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -1000000.00
XYL cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
XYL balance_sheet (quarterly, 2025-06-30) — Net Debt: 826000000.00
XYL income_statement (quarterly, 2025-06-30) — Net Income: 226000000.00
XYL income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 226000000.00
XYL income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 224000000.00
XYL income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 226000000.00
XYL income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 226000000.00
XYL cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 226000000.00
XYL income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 224000000.00
XYL income_statement (quarterly, 2025-06-30) — Net Interest Income: -9000000.00
XYL cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 10000000.00
XYL cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -21000000.00
XYL cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -24000000.00
XYL income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -9000000.00
XYL cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -11000000.00
XYL cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -36000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Net PPE: 1189000000.00
XYL cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 0.00
XYL cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 3000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 483000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Non Current Accrued Expenses: 886000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 427000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 427000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 340000000.00
XYL income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 479000000.00
XYL income_statement (quarterly, 2025-06-30) — Normalized Income: 245478260.87
XYL cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 305000000.00
XYL cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 0.00
XYL income_statement (quarterly, 2025-06-30) — Operating Income: 331000000.00
XYL income_statement (quarterly, 2025-06-30) — Operating Revenue: 2301000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 243351011.00
XYL cash_flow (quarterly, 2025-06-30) — Other Cash Adjustment Outside Changein Cash: 0.00
XYL balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 283000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 68000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -222000000.00
XYL income_statement (quarterly, 2025-06-30) — Other Income Expense: -23000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 2354000000.00
XYL cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 6000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 1042000000.00
XYL income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 3000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Payables: 1215000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1770000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 335000000.00
XYL income_statement (quarterly, 2025-06-30) — Pretax Income: 299000000.00
XYL cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 2000000.00
XYL cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -3000000.00
XYL cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: 1000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Raw Materials: 581000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Receivables: 1837000000.00
XYL income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1409000000.00
XYL income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 145000000.00
XYL cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -24000000.00
XYL cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
XYL income_statement (quarterly, 2025-06-30) — Research And Development: 58000000.00
XYL income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 22000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 3339000000.00
XYL cash_flow (quarterly, 2025-06-30) — Sale Of Business: 2000000.00
XYL cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 9000000.00
XYL cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 0.00
XYL income_statement (quarterly, 2025-06-30) — Selling General And Administration: 503000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Share Issued: 259651011.00
XYL cash_flow (quarterly, 2025-06-30) — Short Term Debt Issuance: 3000000.00
XYL income_statement (quarterly, 2025-06-30) — Special Income Charges: -26000000.00
XYL cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 13000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 11074000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 483000000.00
XYL income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -6521739.13
XYL income_statement (quarterly, 2025-06-30) — Tax Provision: 75000000.00
XYL income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.25
XYL balance_sheet (quarterly, 2025-06-30) — Total Assets: 17191000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 13002000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Total Debt: 2124000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 11309000000.00
XYL income_statement (quarterly, 2025-06-30) — Total Expenses: 1970000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 5882000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 12822000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 3581000000.00
XYL income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 305000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 168000000.00
XYL income_statement (quarterly, 2025-06-30) — Total Unusual Items: -26000000.00
XYL income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -26000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 16300000.00
XYL balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 766000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Work In Process: 113000000.00
XYL balance_sheet (quarterly, 2025-06-30) — Working Capital: 2068000000.00
XYL income_statement (quarterly, 2025-06-30) — Write Off: 4000000.00
XYL income_statement (quarterly, 2025-09-30) — +Operating Expense: 526000000.00
XYL income_statement (quarterly, 2025-09-30) — +Total Revenue: 2268000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 968000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1803000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 8735000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -66000000.00
XYL cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 78000000.00
XYL cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 78000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 158000000.00
XYL income_statement (quarterly, 2025-09-30) — Basic Average Shares: 243500000.00
XYL income_statement (quarterly, 2025-09-30) — Basic EPS: 0.93
XYL cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 1170000000.00
XYL cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -79000000.00
XYL cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -79000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 127000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Capital Stock: 3000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1191000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1191000000.00
XYL cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -97000000.00
XYL cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -138000000.00
XYL cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -189000000.00
XYL cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 360000000.00
XYL cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -51000000.00
XYL cash_flow (quarterly, 2025-09-30) — Change In Inventory: -3000000.00
XYL cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -35000000.00
XYL cash_flow (quarterly, 2025-09-30) — Change In Payable: -63000000.00
XYL cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -13000000.00
XYL cash_flow (quarterly, 2025-09-30) — Change In Receivables: -10000000.00
XYL cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -61000000.00
XYL cash_flow (quarterly, 2025-09-30) — Changes In Cash: 33000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Common Stock: 3000000.00
XYL cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -97000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 11207000000.00
XYL cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -1000000.00
XYL income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1385000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 555000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Current Assets: 4441000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 127000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Current Debt: 49000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 176000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 2269000000.00
XYL cash_flow (quarterly, 2025-09-30) — Depreciation: 64000000.00
XYL cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 142000000.00
XYL cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 142000000.00
XYL income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 244100000.00
XYL income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.93
XYL income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 227000000.00
XYL income_statement (quarterly, 2025-09-30) — EBIT: 303000000.00
XYL income_statement (quarterly, 2025-09-30) — EBITDA: 445000000.00
XYL cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -1000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 323000000.00
XYL cash_flow (quarterly, 2025-09-30) — End Cash Position: 1191000000.00
XYL cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -138000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Finished Goods: 367000000.00
XYL cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 281000000.00
XYL cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of Business: 37000000.00
XYL income_statement (quarterly, 2025-09-30) — Gain On Sale Of Business: -37000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -233000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Goodwill: 8280000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 10599000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 1869000000.00
XYL income_statement (quarterly, 2025-09-30) — Gross Profit: 883000000.00
XYL cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 33000000.00
XYL income_statement (quarterly, 2025-09-30) — Interest Expense: 6000000.00
XYL income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 6000000.00
XYL cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 11000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Inventory: 1035000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Invested Capital: 13169000000.00
XYL cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -189000000.00
XYL cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: -3000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 1913000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1913000000.00
XYL cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -32000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Minority Interest: 238000000.00
XYL income_statement (quarterly, 2025-09-30) — Minority Interests: 1000000.00
XYL cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -110000000.00
XYL cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -1000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Net Debt: 771000000.00
XYL income_statement (quarterly, 2025-09-30) — Net Income: 227000000.00
XYL income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 227000000.00
XYL income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 226000000.00
XYL income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 227000000.00
XYL income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 227000000.00
XYL cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 222000000.00
XYL income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 226000000.00
XYL income_statement (quarterly, 2025-09-30) — Net Interest Income: -6000000.00
XYL cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -11000000.00
XYL cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -35000000.00
XYL cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -32000000.00
XYL income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -6000000.00
XYL cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -8000000.00
XYL cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 1000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Net PPE: 1141000000.00
XYL cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 10000000.00
XYL cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -3000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 608000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Non Current Accrued Expenses: 853000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 492000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 492000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 323000000.00
XYL income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 505000000.00
XYL income_statement (quarterly, 2025-09-30) — Normalized Income: 272660000.00
XYL cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 360000000.00
XYL cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 37000000.00
XYL income_statement (quarterly, 2025-09-30) — Operating Income: 357000000.00
XYL income_statement (quarterly, 2025-09-30) — Operating Revenue: 2268000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 243500000.00
XYL balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 254000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 49000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 80000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -233000000.00
XYL income_statement (quarterly, 2025-09-30) — Other Income Expense: -54000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 2319000000.00
XYL cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 8000000.00
XYL balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 1114000000.00